0.0022GBp-99.00%Mkt Cap: 1.42M GBpP/E: —Last update: 2026-05-29
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary C…
Industry Peers
Medical Care Facilities87.66BTRYP/E 15.5
82.76BUSDP/E 12.9
31.03BSEKP/E 36.2
19.97BEURP/E 13.2
16.19BSEKP/E 19.2
14.78BUSDP/E 8.9
12.32BUSDP/E 18.5
11.64BSEKP/E 17.0
Indicators:|
Key Statistics
Company
Market Cap1.42M GBp
Enterprise Value-503.66K GBp
Revenue (TTM)1.14M GBp
Gross Profit134.00K GBp
Net Income (TTM)-7.99M GBp
Revenue/Share0.0020 GBp
Last Price0.0022 GBp
Fiscal Year EndDec 2023
MR QuarterJun 2024
Employees20
CountryGB
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA0.19
EV/Revenue-0.44
P/S1.25
P/B0.25
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.00220% of range0.2250
52W High0.2250 GBp
52W Low0.0022 GBp
Profitability
Gross Margin14.97%
Oper. Margin-244.38%
EBITDA Margin-236.75%
Profit Margin-892.40%
ROE-106.31%
ROA-95.64%
Growth
Revenue Growth54.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.52M GBp
CapEx (TTM)533.00K GBp
FCF Margin-74.81%
FCF Yield-59.94%
Net Debt-1.88M GBp
Net Debt/EBITDA0.70
Balance Sheet
Debt/Equity0.04
Current Ratio2.78
Quick Ratio2.72
Book Value/Sh0.0090 GBp
Cash/Share0.0030 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.632.43M
Float379.46M
Insiders6.29%
Institutions0.05%
Technical
SMA 500.0646 (-96.5%)
SMA 2000.0178 (-87.4%)
Beta2.30
S&P 52W Chg27.94%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)67.6
MACD0.0593
MACD Signal0.0512
MACD Hist.+0.0082
BB Upper0.3522 GBp
BB Middle0.1248 GBp
BB Lower-0.1026 GBp
BB Width364.52%
ATR (14)0.0217 GBp
Vol Ratio (20d)—